PBPK modeling to support bioequivalence & generic product approvals
Physiologically-based pharmacokinetic modeling can be used to support bioequivalence (BE) assessment of complex and locally…
Certara2024 年 11 月 12 日
Mathematical models can assist in broadening use of immuno-oncology drugs to treat autoimmunity
2024 年 10 月 31 日 The level of immune activation is enormously influential for the progression of…
Certara2024 年 10 月 31 日
RAPS Sponsored Webcast: Optimizing Pediatric Oncology Drug Development: A Comprehensive Overview
Developing safe and effective oncology medications for children presents unique challenges due to ethical considerations…
Certara2024 年 10 月 17 日
